KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Novartis Ag (NVS) Return on Sales (2016 - 2025)

Historic Return on Sales for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to 3.89%.

  • Novartis Ag's Return on Sales rose 36400.0% to 3.89% in Q4 2025 from the same period last year, while for Dec 2025 it was 4.98%, marking a year-over-year increase of 47100.0%. This contributed to the annual value of 0.26% for FY2025, which is 200.0% up from last year.
  • Per Novartis Ag's latest filing, its Return on Sales stood at 3.89% for Q4 2025, which was up 36400.0% from 5.75% recorded in Q3 2025.
  • Novartis Ag's Return on Sales' 5-year high stood at 6.71% during Q1 2025, with a 5-year trough of 0.0% in Q2 2023.
  • Moreover, its 5-year median value for Return on Sales was 0.26% (2024), whereas its average is 1.23%.
  • In the last 5 years, Novartis Ag's Return on Sales crashed by -12700bps in 2022 and then surged by 64400bps in 2025.
  • Quarter analysis of 5 years shows Novartis Ag's Return on Sales stood at 1.28% in 2021, then plummeted by -99bps to 0.01% in 2022, then skyrocketed by 3482bps to 0.51% in 2023, then plummeted by -51bps to 0.25% in 2024, then surged by 1456bps to 3.89% in 2025.
  • Its Return on Sales stands at 3.89% for Q4 2025, versus 5.75% for Q3 2025 and 4.23% for Q2 2025.